Alan K Burnett Selected Research

Alan K Burnett Research Topics

Disease

46	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 03/2002
13	Neoplasms (Cancer) 02/2016 - 03/2002
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 10/2004
8	Leukemia 02/2016 - 03/2005
7	Residual Neoplasm 01/2022 - 08/2009
5	Acute Promyelocytic Leukemia 11/2019 - 11/2005
2	Hemorrhage 11/2019 - 02/2009
2	Pathologic Complete Response 06/2015 - 10/2005
2	Hematologic Neoplasms (Hematological Malignancy) 10/2010 - 03/2007
2	Multiple Myeloma 06/2010 - 03/2007
2	Infections 08/2009 - 06/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2008 - 05/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2008 - 12/2005
2	Hemochromatosis (Bronze Diabetes) 03/2005 - 03/2002
1	Alopecia (Baldness) 10/2015
1	Necrosis 01/2013
1	Genetic Translocation (Chromosomal Translocation) 10/2011
1	Congenital Preauricular Fistulae 10/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2011
1	Thrombocytopenia (Thrombopenia) 10/2010
1	monosomy Chromosome 7 06/2010
1	Cytopenia 08/2009
1	Febrile Neutropenia 08/2009
1	Disease Progression 05/2008
1	Breast Neoplasms (Breast Cancer) 05/2007

Drug/Important Bio-Agent (IBA)

12	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2021 - 10/2004
6	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2016 - 10/2005
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 05/2012 - 01/2003
4	Arsenic Trioxide (Trisenox)FDA Link 11/2019 - 02/2009
4	Gemtuzumab (Mylotarg)FDA Link 08/2014 - 12/2003
3	fms-Like Tyrosine Kinase 3IBA 10/2019 - 11/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 02/2010
3	Clofarabine (Clolar)FDA Link 08/2013 - 05/2010
3	NF-kappa B (NF-kB)IBA 06/2010 - 05/2008
3	tipifarnib (R115777)IBA 08/2009 - 03/2007
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2009 - 10/2004
3	fludarabineIBA 12/2008 - 10/2004
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 08/2007
2	NucleophosminIBA 02/2016 - 03/2008
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 10/2015 - 10/2004
2	vosaroxinIBA 05/2015 - 03/2011
2	Phosphotransferases (Kinase)IBA 05/2014 - 05/2007
2	Core Binding Factors (Core-Binding Factor)IBA 10/2012 - 06/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2011 - 10/2010
2	Etoposide (VP 16)FDA LinkGeneric 03/2011 - 06/2006
2	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 05/2008
2	Indicators and Reagents (Reagents)IBA 06/2010 - 11/2005
2	Bortezomib (Velcade)FDA Link 06/2010 - 03/2007
2	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2009 - 03/2007
2	valspodar (PSC 833)IBA 05/2009 - 10/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2007 - 11/2005
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2007 - 10/2005
2	Transferrin Receptors (Transferrin Receptor)IBA 03/2005 - 03/2002
2	IronIBA 03/2005 - 03/2002
1	quizartinibIBA 12/2021
1	flt3 ligand protein (flt3 ligand)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	TOR Serine-Threonine KinasesIBA 10/2018
1	Everolimus FDA Link 10/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2016
1	Alanine Transaminase (SGPT)IBA 10/2015
1	Protein Kinases (Protein Kinase)IBA 05/2014
1	NADP (NADPH)IBA 11/2013
1	Oxidoreductases (Dehydrogenase)IBA 11/2013
1	NucleosidesIBA 08/2013
1	LigandsIBA 01/2013
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 01/2013
1	N 556IBA 11/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2012
1	Molecular Chaperones (Chaperone, Molecular)IBA 05/2012
1	Lysine (L-Lysine)FDA Link 10/2011
1	GSK1210151AIBA 10/2011
1	ChromatinIBA 10/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2011
1	EnzymesIBA 03/2011
1	QuinolonesIBA 03/2011
1	PoisonsIBA 03/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2011
1	Topoisomerase II InhibitorsIBA 03/2011
1	AminopeptidasesIBA 10/2010
1	tosedostatIBA 10/2010
1	AT 130IBA 10/2010
1	CCAAT-Enhancer-Binding Protein-alphaIBA 06/2010
1	Pyridinolcarbamate (P23)IBA 06/2010
1	Cytotoxins (Cytolysins)IBA 05/2010
1	AnthracyclinesIBA 08/2009
1	major vault proteinIBA 05/2007
1	Proteasome InhibitorsIBA 03/2007

Therapy/Procedure

19	Therapeutics 01/2023 - 11/2005
19	Drug Therapy (Chemotherapy) 12/2021 - 03/2002
5	Transplantation 01/2022 - 11/2005
3	Induction Chemotherapy 10/2018 - 10/2005
2	Homologous Transplantation 01/2022 - 02/2008
2	Salvage Therapy 11/2019 - 02/2009
1	Cell Transplantation 01/2020
1	Ligation 03/2011
1	Maintenance Chemotherapy 02/2008
1	Autologous Transplantation 02/2008
1	Stem Cell Transplantation 03/2007